NBIO insider transaction filings
Nascent Biotech Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-07-02. Screen NBIO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for NBIO between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Nascent Biotech Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-02 | 4 | Karas Douglas John — Director | Other (J): 50,000 @ $0.10 | EDGAR |
| 2024-07-02 | 4 | Carrick Sean — President & CEO, Director, 10% owner | Other (J): 192,000 @ $0.09 | EDGAR |
| 2024-07-02 | 4 | HOLDEN LOWELL THOMAS — CFO, Director | Other (J): 96,000 @ $0.09 | EDGAR |
| 2024-04-10 | 4 | Carrick Sean — President & CEO, Director, 10% owner | Other (J): 225,000 @ $0.18 | EDGAR |
| 2024-04-10 | 4 | Karas Douglas John — Director | Other (J): 27,100 @ $0.18 | EDGAR |
| 2024-04-10 | 4 | HOLDEN LOWELL THOMAS — CFO, Director | Other (J): 112,500 @ $0.18 | EDGAR |
| 2024-02-27 | 4 | Carrick Sean — President & CEO, Director, 10% owner | Other (J): 239,300 @ $0.17 | EDGAR |
| 2024-02-27 | 4 | Karas Douglas John — Director | Other (J): 28,935 @ $0.18 | EDGAR |
| 2024-02-27 | 4 | HOLDEN LOWELL THOMAS — CFO, Director | Other (J): 119,650 @ $0.17 | EDGAR |
Recent 8-K events — Nascent Biotech Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-01-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-12-19 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NBIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →